Disturbances in the balance between NKCC1 and KCC2 activity may reduce the hyperpolarizing effects of gamma-aminobutyric acid (GABA), which may influence the occurrence of epilepsy in GBM patients. The gene discussed is SLC12A2; the disease is epilepsy.